Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European UnionBusiness Wire • 07/25/25
Pfizer's ‘Depo-Provera' Increases Risk of Brain Tumours 3.5 Times Compared to Combined Birth Control Pill According to New Study as Litigation Overseen by Levin Papantonio Rises to Over 550 LawsuitsGlobeNewsWire • 07/24/25
Here's What to Expect From Pfizer's Non-Oncology Drugs in Q2 EarningsZacks Investment Research • 07/23/25
8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling GrowthGlobeNewsWire • 07/23/25
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 Right NowThe Motley Fool • 07/19/25
Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discountCNBC • 07/17/25
Dividend Harvesting Portfolio Week 228: $22,800 Allocated, $2,399.27 In Projected DividendsSeeking Alpha • 07/17/25
Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash priceWSJ • 07/17/25
This Once-Dominant Healthcare Stock Down 50% Is Finally Ready for a ComebackThe Motley Fool • 07/16/25
Oxford BioDynamics shares jump 66% after Pfizer validates blood-based cancer biomarker technologyProactive Investors • 07/15/25
“Nobody Ever Went Broke Taking a Profit” – Grab The Highest-Yielding S&P 500 Stocks Right Now24/7 Wall Street • 07/11/25